Biotech Currents

Biotech Currents

Share this post

Biotech Currents
Biotech Currents
[Complimentary] New Amsterdam repositions obicetrapib selectively for advanced cardiovascular disease patients | $NAMS

[Complimentary] New Amsterdam repositions…

Bill Langbein
Oct 28, 2024

Share this post

Biotech Currents
Biotech Currents
[Complimentary] New Amsterdam repositions obicetrapib selectively for advanced cardiovascular disease patients | $NAMS

Assigning a 63.4% overall probability

Read →
Comments
User's avatar
© 2025 Bill Langbein
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share